Influence of N-methyl-D-aspartate receptors on ouabain activation of nuclear factor-κB in the rat hippocampus
It has been shown that ouabain (OUA) can activate the Na,K‐ATPase complex and mediate intracellular signaling in the central nervous system (CNS). Inflammatory stimulus increases glutamatergic transmission, especially at N‐methyl‐D‐aspartate (NMDA) receptors, which are usually coupled to the activat...
Gespeichert in:
Veröffentlicht in: | Journal of neuroscience research 2012-01, Vol.90 (1), p.213-228 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 228 |
---|---|
container_issue | 1 |
container_start_page | 213 |
container_title | Journal of neuroscience research |
container_volume | 90 |
creator | Kawamoto, E.M. Lima, L.S. Munhoz, C.D. Yshii, L.M. Kinoshita, P.F. Amara, F.G. Pestana, R.R.F. Orellana, A.M.M. Cipolla-Neto, J. Britto, L.R.G. Avellar, M.C.W. Rossoni, L.V. Scavone, C. |
description | It has been shown that ouabain (OUA) can activate the Na,K‐ATPase complex and mediate intracellular signaling in the central nervous system (CNS). Inflammatory stimulus increases glutamatergic transmission, especially at N‐methyl‐D‐aspartate (NMDA) receptors, which are usually coupled to the activation of nitric oxide synthase (NOS). Nuclear factor‐κB (NF‐κB) activation modulates the expression of genes involved in development, plasticity, and inflammation. The present work investigated the effects of OUA on NF‐κB binding activity in rat hippocampus and the influence of this OUA‐Na,K‐ATPase signaling cascade in NMDA‐mediated NF‐κB activation. The findings presented here are the first report indicating that intrahippocampal administration of OUA, in a concentration that did not alter Na,K‐ATPase or NOS activity, induced an activation of NF‐κB, leading to increases in brain‐derived neurotrophic factor (Bdnf), inducible NOS (iNos), tumor necrosis factor‐α (Tnf‐α), and B‐cell leukemia/lymphoma 2 (Bcl2) mRNA levels. This response was not linked to any significant signs of neurodegeneration as showed via Fluoro‐Jade B and Nissl stain. Intrahippocampal administration of NMDA induced NF‐κB activation and increased NOS and α2/3‐Na,K‐ATPase activities. NMDA treatment further increased OUA‐induced NF‐κB activation, which was partially blocked by MK‐801, an antagonist of NMDA receptor. These results suggest that OUA‐induced NF‐κB activation is at least in part dependent on Na,K‐ATPase modulatory action of NMDA receptor in hippocampus. The interaction of these signaling pathways could be associated with biological mechanisms that may underlie the basal homeostatic state linked to the inflammatory signaling cascade in the brain. © 2011 Wiley Periodicals, Inc. |
doi_str_mv | 10.1002/jnr.22745 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_905671410</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>905671410</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3625-c594326e55671aaae2a542bad988ed0ebba15db392ce759361271d4d26243adf3</originalsourceid><addsrcrecordid>eNp1kM1u1DAURi1ERYfCghdA3iEWbv2bjJe0hbZoNBUFxNK6cW40KUkcbAeYV-MheKZmmLY7Vle6Ot9ZHEJeCX4sOJcnt0M8lrLU5glZCG5Lpo0un5IFVwVnmgt5SJ6ndMs5t9aoZ-RQSs6LolwuyHA1NN2Eg0caGrpmPebNtmPnDNIIMUNGGtHjmENMNAw0TFBBO1Dwuf0Jud29GjpMvkOItJnfIbK_f07pzOTNPIZMN-04Bg_9OKUX5KCBLuHL-3tEvn54_-Xskq2uL67O3q2YV4U0zBurlSzQmKIUAIASjJYV1Ha5xJpjVYEwdaWs9FgaqwohS1HrWhZSK6gbdUTe7L1jDD8mTNn1bfLYdTBgmJKzfGfWgs_k2z3pY0gpYuPG2PYQt05wt6vr5rruX92ZfX1vnaoe60fyIecMnOyBX22H2_-b3Mf1zYOS7Rdtyvj7cQHxuytKVRr3bX3hPtmbz6crxd25ugOl_pSY</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>905671410</pqid></control><display><type>article</type><title>Influence of N-methyl-D-aspartate receptors on ouabain activation of nuclear factor-κB in the rat hippocampus</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>Kawamoto, E.M. ; Lima, L.S. ; Munhoz, C.D. ; Yshii, L.M. ; Kinoshita, P.F. ; Amara, F.G. ; Pestana, R.R.F. ; Orellana, A.M.M. ; Cipolla-Neto, J. ; Britto, L.R.G. ; Avellar, M.C.W. ; Rossoni, L.V. ; Scavone, C.</creator><creatorcontrib>Kawamoto, E.M. ; Lima, L.S. ; Munhoz, C.D. ; Yshii, L.M. ; Kinoshita, P.F. ; Amara, F.G. ; Pestana, R.R.F. ; Orellana, A.M.M. ; Cipolla-Neto, J. ; Britto, L.R.G. ; Avellar, M.C.W. ; Rossoni, L.V. ; Scavone, C.</creatorcontrib><description>It has been shown that ouabain (OUA) can activate the Na,K‐ATPase complex and mediate intracellular signaling in the central nervous system (CNS). Inflammatory stimulus increases glutamatergic transmission, especially at N‐methyl‐D‐aspartate (NMDA) receptors, which are usually coupled to the activation of nitric oxide synthase (NOS). Nuclear factor‐κB (NF‐κB) activation modulates the expression of genes involved in development, plasticity, and inflammation. The present work investigated the effects of OUA on NF‐κB binding activity in rat hippocampus and the influence of this OUA‐Na,K‐ATPase signaling cascade in NMDA‐mediated NF‐κB activation. The findings presented here are the first report indicating that intrahippocampal administration of OUA, in a concentration that did not alter Na,K‐ATPase or NOS activity, induced an activation of NF‐κB, leading to increases in brain‐derived neurotrophic factor (Bdnf), inducible NOS (iNos), tumor necrosis factor‐α (Tnf‐α), and B‐cell leukemia/lymphoma 2 (Bcl2) mRNA levels. This response was not linked to any significant signs of neurodegeneration as showed via Fluoro‐Jade B and Nissl stain. Intrahippocampal administration of NMDA induced NF‐κB activation and increased NOS and α2/3‐Na,K‐ATPase activities. NMDA treatment further increased OUA‐induced NF‐κB activation, which was partially blocked by MK‐801, an antagonist of NMDA receptor. These results suggest that OUA‐induced NF‐κB activation is at least in part dependent on Na,K‐ATPase modulatory action of NMDA receptor in hippocampus. The interaction of these signaling pathways could be associated with biological mechanisms that may underlie the basal homeostatic state linked to the inflammatory signaling cascade in the brain. © 2011 Wiley Periodicals, Inc.</description><identifier>ISSN: 0360-4012</identifier><identifier>EISSN: 1097-4547</identifier><identifier>DOI: 10.1002/jnr.22745</identifier><identifier>PMID: 22006678</identifier><language>eng</language><publisher>Hoboken: Wiley Subscription Services, Inc., A Wiley Company</publisher><subject>Analysis of Variance ; Animals ; bcl-2-Associated X Protein - genetics ; bcl-2-Associated X Protein - metabolism ; Brain-Derived Neurotrophic Factor - genetics ; Brain-Derived Neurotrophic Factor - metabolism ; Cell Death - drug effects ; Dizocilpine Maleate - pharmacology ; Dose-Response Relationship, Drug ; Drug Interactions ; Electrophoretic Mobility Shift Assay - methods ; Enzyme Activation - drug effects ; Enzyme Inhibitors - pharmacology ; Excitatory Amino Acid Antagonists - pharmacology ; Gene Expression Regulation, Enzymologic - drug effects ; glutamate ; Hippocampus - cytology ; Hippocampus - drug effects ; K-ATPase ; Male ; N-methyl-D-aspartate ; N-Methylaspartate - pharmacology ; Na,K‐ATPase ; Neurons - cytology ; Neurons - drug effects ; NF-kappa B - metabolism ; NF-κB ; Nitric Oxide Synthase Type II - genetics ; Nitric Oxide Synthase Type II - metabolism ; Oligonucleotides - pharmacology ; ouabain ; Ouabain - pharmacology ; Proto-Oncogene Proteins c-bcl-2 - genetics ; Proto-Oncogene Proteins c-bcl-2 - metabolism ; Rats ; Rats, Wistar ; Receptors, N-Methyl-D-Aspartate - metabolism ; RNA, Messenger - metabolism ; Sodium-Potassium-Exchanging ATPase - metabolism ; Time Factors ; Tumor Necrosis Factor-alpha - genetics ; Tumor Necrosis Factor-alpha - metabolism</subject><ispartof>Journal of neuroscience research, 2012-01, Vol.90 (1), p.213-228</ispartof><rights>Copyright © 2011 Wiley Periodicals, Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3625-c594326e55671aaae2a542bad988ed0ebba15db392ce759361271d4d26243adf3</citedby><cites>FETCH-LOGICAL-c3625-c594326e55671aaae2a542bad988ed0ebba15db392ce759361271d4d26243adf3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fjnr.22745$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fjnr.22745$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27901,27902,45550,45551</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/22006678$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kawamoto, E.M.</creatorcontrib><creatorcontrib>Lima, L.S.</creatorcontrib><creatorcontrib>Munhoz, C.D.</creatorcontrib><creatorcontrib>Yshii, L.M.</creatorcontrib><creatorcontrib>Kinoshita, P.F.</creatorcontrib><creatorcontrib>Amara, F.G.</creatorcontrib><creatorcontrib>Pestana, R.R.F.</creatorcontrib><creatorcontrib>Orellana, A.M.M.</creatorcontrib><creatorcontrib>Cipolla-Neto, J.</creatorcontrib><creatorcontrib>Britto, L.R.G.</creatorcontrib><creatorcontrib>Avellar, M.C.W.</creatorcontrib><creatorcontrib>Rossoni, L.V.</creatorcontrib><creatorcontrib>Scavone, C.</creatorcontrib><title>Influence of N-methyl-D-aspartate receptors on ouabain activation of nuclear factor-κB in the rat hippocampus</title><title>Journal of neuroscience research</title><addtitle>J. Neurosci. Res</addtitle><description>It has been shown that ouabain (OUA) can activate the Na,K‐ATPase complex and mediate intracellular signaling in the central nervous system (CNS). Inflammatory stimulus increases glutamatergic transmission, especially at N‐methyl‐D‐aspartate (NMDA) receptors, which are usually coupled to the activation of nitric oxide synthase (NOS). Nuclear factor‐κB (NF‐κB) activation modulates the expression of genes involved in development, plasticity, and inflammation. The present work investigated the effects of OUA on NF‐κB binding activity in rat hippocampus and the influence of this OUA‐Na,K‐ATPase signaling cascade in NMDA‐mediated NF‐κB activation. The findings presented here are the first report indicating that intrahippocampal administration of OUA, in a concentration that did not alter Na,K‐ATPase or NOS activity, induced an activation of NF‐κB, leading to increases in brain‐derived neurotrophic factor (Bdnf), inducible NOS (iNos), tumor necrosis factor‐α (Tnf‐α), and B‐cell leukemia/lymphoma 2 (Bcl2) mRNA levels. This response was not linked to any significant signs of neurodegeneration as showed via Fluoro‐Jade B and Nissl stain. Intrahippocampal administration of NMDA induced NF‐κB activation and increased NOS and α2/3‐Na,K‐ATPase activities. NMDA treatment further increased OUA‐induced NF‐κB activation, which was partially blocked by MK‐801, an antagonist of NMDA receptor. These results suggest that OUA‐induced NF‐κB activation is at least in part dependent on Na,K‐ATPase modulatory action of NMDA receptor in hippocampus. The interaction of these signaling pathways could be associated with biological mechanisms that may underlie the basal homeostatic state linked to the inflammatory signaling cascade in the brain. © 2011 Wiley Periodicals, Inc.</description><subject>Analysis of Variance</subject><subject>Animals</subject><subject>bcl-2-Associated X Protein - genetics</subject><subject>bcl-2-Associated X Protein - metabolism</subject><subject>Brain-Derived Neurotrophic Factor - genetics</subject><subject>Brain-Derived Neurotrophic Factor - metabolism</subject><subject>Cell Death - drug effects</subject><subject>Dizocilpine Maleate - pharmacology</subject><subject>Dose-Response Relationship, Drug</subject><subject>Drug Interactions</subject><subject>Electrophoretic Mobility Shift Assay - methods</subject><subject>Enzyme Activation - drug effects</subject><subject>Enzyme Inhibitors - pharmacology</subject><subject>Excitatory Amino Acid Antagonists - pharmacology</subject><subject>Gene Expression Regulation, Enzymologic - drug effects</subject><subject>glutamate</subject><subject>Hippocampus - cytology</subject><subject>Hippocampus - drug effects</subject><subject>K-ATPase</subject><subject>Male</subject><subject>N-methyl-D-aspartate</subject><subject>N-Methylaspartate - pharmacology</subject><subject>Na,K‐ATPase</subject><subject>Neurons - cytology</subject><subject>Neurons - drug effects</subject><subject>NF-kappa B - metabolism</subject><subject>NF-κB</subject><subject>Nitric Oxide Synthase Type II - genetics</subject><subject>Nitric Oxide Synthase Type II - metabolism</subject><subject>Oligonucleotides - pharmacology</subject><subject>ouabain</subject><subject>Ouabain - pharmacology</subject><subject>Proto-Oncogene Proteins c-bcl-2 - genetics</subject><subject>Proto-Oncogene Proteins c-bcl-2 - metabolism</subject><subject>Rats</subject><subject>Rats, Wistar</subject><subject>Receptors, N-Methyl-D-Aspartate - metabolism</subject><subject>RNA, Messenger - metabolism</subject><subject>Sodium-Potassium-Exchanging ATPase - metabolism</subject><subject>Time Factors</subject><subject>Tumor Necrosis Factor-alpha - genetics</subject><subject>Tumor Necrosis Factor-alpha - metabolism</subject><issn>0360-4012</issn><issn>1097-4547</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kM1u1DAURi1ERYfCghdA3iEWbv2bjJe0hbZoNBUFxNK6cW40KUkcbAeYV-MheKZmmLY7Vle6Ot9ZHEJeCX4sOJcnt0M8lrLU5glZCG5Lpo0un5IFVwVnmgt5SJ6ndMs5t9aoZ-RQSs6LolwuyHA1NN2Eg0caGrpmPebNtmPnDNIIMUNGGtHjmENMNAw0TFBBO1Dwuf0Jud29GjpMvkOItJnfIbK_f07pzOTNPIZMN-04Bg_9OKUX5KCBLuHL-3tEvn54_-Xskq2uL67O3q2YV4U0zBurlSzQmKIUAIASjJYV1Ha5xJpjVYEwdaWs9FgaqwohS1HrWhZSK6gbdUTe7L1jDD8mTNn1bfLYdTBgmJKzfGfWgs_k2z3pY0gpYuPG2PYQt05wt6vr5rruX92ZfX1vnaoe60fyIecMnOyBX22H2_-b3Mf1zYOS7Rdtyvj7cQHxuytKVRr3bX3hPtmbz6crxd25ugOl_pSY</recordid><startdate>201201</startdate><enddate>201201</enddate><creator>Kawamoto, E.M.</creator><creator>Lima, L.S.</creator><creator>Munhoz, C.D.</creator><creator>Yshii, L.M.</creator><creator>Kinoshita, P.F.</creator><creator>Amara, F.G.</creator><creator>Pestana, R.R.F.</creator><creator>Orellana, A.M.M.</creator><creator>Cipolla-Neto, J.</creator><creator>Britto, L.R.G.</creator><creator>Avellar, M.C.W.</creator><creator>Rossoni, L.V.</creator><creator>Scavone, C.</creator><general>Wiley Subscription Services, Inc., A Wiley Company</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>201201</creationdate><title>Influence of N-methyl-D-aspartate receptors on ouabain activation of nuclear factor-κB in the rat hippocampus</title><author>Kawamoto, E.M. ; Lima, L.S. ; Munhoz, C.D. ; Yshii, L.M. ; Kinoshita, P.F. ; Amara, F.G. ; Pestana, R.R.F. ; Orellana, A.M.M. ; Cipolla-Neto, J. ; Britto, L.R.G. ; Avellar, M.C.W. ; Rossoni, L.V. ; Scavone, C.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3625-c594326e55671aaae2a542bad988ed0ebba15db392ce759361271d4d26243adf3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Analysis of Variance</topic><topic>Animals</topic><topic>bcl-2-Associated X Protein - genetics</topic><topic>bcl-2-Associated X Protein - metabolism</topic><topic>Brain-Derived Neurotrophic Factor - genetics</topic><topic>Brain-Derived Neurotrophic Factor - metabolism</topic><topic>Cell Death - drug effects</topic><topic>Dizocilpine Maleate - pharmacology</topic><topic>Dose-Response Relationship, Drug</topic><topic>Drug Interactions</topic><topic>Electrophoretic Mobility Shift Assay - methods</topic><topic>Enzyme Activation - drug effects</topic><topic>Enzyme Inhibitors - pharmacology</topic><topic>Excitatory Amino Acid Antagonists - pharmacology</topic><topic>Gene Expression Regulation, Enzymologic - drug effects</topic><topic>glutamate</topic><topic>Hippocampus - cytology</topic><topic>Hippocampus - drug effects</topic><topic>K-ATPase</topic><topic>Male</topic><topic>N-methyl-D-aspartate</topic><topic>N-Methylaspartate - pharmacology</topic><topic>Na,K‐ATPase</topic><topic>Neurons - cytology</topic><topic>Neurons - drug effects</topic><topic>NF-kappa B - metabolism</topic><topic>NF-κB</topic><topic>Nitric Oxide Synthase Type II - genetics</topic><topic>Nitric Oxide Synthase Type II - metabolism</topic><topic>Oligonucleotides - pharmacology</topic><topic>ouabain</topic><topic>Ouabain - pharmacology</topic><topic>Proto-Oncogene Proteins c-bcl-2 - genetics</topic><topic>Proto-Oncogene Proteins c-bcl-2 - metabolism</topic><topic>Rats</topic><topic>Rats, Wistar</topic><topic>Receptors, N-Methyl-D-Aspartate - metabolism</topic><topic>RNA, Messenger - metabolism</topic><topic>Sodium-Potassium-Exchanging ATPase - metabolism</topic><topic>Time Factors</topic><topic>Tumor Necrosis Factor-alpha - genetics</topic><topic>Tumor Necrosis Factor-alpha - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kawamoto, E.M.</creatorcontrib><creatorcontrib>Lima, L.S.</creatorcontrib><creatorcontrib>Munhoz, C.D.</creatorcontrib><creatorcontrib>Yshii, L.M.</creatorcontrib><creatorcontrib>Kinoshita, P.F.</creatorcontrib><creatorcontrib>Amara, F.G.</creatorcontrib><creatorcontrib>Pestana, R.R.F.</creatorcontrib><creatorcontrib>Orellana, A.M.M.</creatorcontrib><creatorcontrib>Cipolla-Neto, J.</creatorcontrib><creatorcontrib>Britto, L.R.G.</creatorcontrib><creatorcontrib>Avellar, M.C.W.</creatorcontrib><creatorcontrib>Rossoni, L.V.</creatorcontrib><creatorcontrib>Scavone, C.</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of neuroscience research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kawamoto, E.M.</au><au>Lima, L.S.</au><au>Munhoz, C.D.</au><au>Yshii, L.M.</au><au>Kinoshita, P.F.</au><au>Amara, F.G.</au><au>Pestana, R.R.F.</au><au>Orellana, A.M.M.</au><au>Cipolla-Neto, J.</au><au>Britto, L.R.G.</au><au>Avellar, M.C.W.</au><au>Rossoni, L.V.</au><au>Scavone, C.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Influence of N-methyl-D-aspartate receptors on ouabain activation of nuclear factor-κB in the rat hippocampus</atitle><jtitle>Journal of neuroscience research</jtitle><addtitle>J. Neurosci. Res</addtitle><date>2012-01</date><risdate>2012</risdate><volume>90</volume><issue>1</issue><spage>213</spage><epage>228</epage><pages>213-228</pages><issn>0360-4012</issn><eissn>1097-4547</eissn><abstract>It has been shown that ouabain (OUA) can activate the Na,K‐ATPase complex and mediate intracellular signaling in the central nervous system (CNS). Inflammatory stimulus increases glutamatergic transmission, especially at N‐methyl‐D‐aspartate (NMDA) receptors, which are usually coupled to the activation of nitric oxide synthase (NOS). Nuclear factor‐κB (NF‐κB) activation modulates the expression of genes involved in development, plasticity, and inflammation. The present work investigated the effects of OUA on NF‐κB binding activity in rat hippocampus and the influence of this OUA‐Na,K‐ATPase signaling cascade in NMDA‐mediated NF‐κB activation. The findings presented here are the first report indicating that intrahippocampal administration of OUA, in a concentration that did not alter Na,K‐ATPase or NOS activity, induced an activation of NF‐κB, leading to increases in brain‐derived neurotrophic factor (Bdnf), inducible NOS (iNos), tumor necrosis factor‐α (Tnf‐α), and B‐cell leukemia/lymphoma 2 (Bcl2) mRNA levels. This response was not linked to any significant signs of neurodegeneration as showed via Fluoro‐Jade B and Nissl stain. Intrahippocampal administration of NMDA induced NF‐κB activation and increased NOS and α2/3‐Na,K‐ATPase activities. NMDA treatment further increased OUA‐induced NF‐κB activation, which was partially blocked by MK‐801, an antagonist of NMDA receptor. These results suggest that OUA‐induced NF‐κB activation is at least in part dependent on Na,K‐ATPase modulatory action of NMDA receptor in hippocampus. The interaction of these signaling pathways could be associated with biological mechanisms that may underlie the basal homeostatic state linked to the inflammatory signaling cascade in the brain. © 2011 Wiley Periodicals, Inc.</abstract><cop>Hoboken</cop><pub>Wiley Subscription Services, Inc., A Wiley Company</pub><pmid>22006678</pmid><doi>10.1002/jnr.22745</doi><tpages>16</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0360-4012 |
ispartof | Journal of neuroscience research, 2012-01, Vol.90 (1), p.213-228 |
issn | 0360-4012 1097-4547 |
language | eng |
recordid | cdi_proquest_miscellaneous_905671410 |
source | MEDLINE; Wiley Online Library Journals Frontfile Complete |
subjects | Analysis of Variance Animals bcl-2-Associated X Protein - genetics bcl-2-Associated X Protein - metabolism Brain-Derived Neurotrophic Factor - genetics Brain-Derived Neurotrophic Factor - metabolism Cell Death - drug effects Dizocilpine Maleate - pharmacology Dose-Response Relationship, Drug Drug Interactions Electrophoretic Mobility Shift Assay - methods Enzyme Activation - drug effects Enzyme Inhibitors - pharmacology Excitatory Amino Acid Antagonists - pharmacology Gene Expression Regulation, Enzymologic - drug effects glutamate Hippocampus - cytology Hippocampus - drug effects K-ATPase Male N-methyl-D-aspartate N-Methylaspartate - pharmacology Na,K‐ATPase Neurons - cytology Neurons - drug effects NF-kappa B - metabolism NF-κB Nitric Oxide Synthase Type II - genetics Nitric Oxide Synthase Type II - metabolism Oligonucleotides - pharmacology ouabain Ouabain - pharmacology Proto-Oncogene Proteins c-bcl-2 - genetics Proto-Oncogene Proteins c-bcl-2 - metabolism Rats Rats, Wistar Receptors, N-Methyl-D-Aspartate - metabolism RNA, Messenger - metabolism Sodium-Potassium-Exchanging ATPase - metabolism Time Factors Tumor Necrosis Factor-alpha - genetics Tumor Necrosis Factor-alpha - metabolism |
title | Influence of N-methyl-D-aspartate receptors on ouabain activation of nuclear factor-κB in the rat hippocampus |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-05T15%3A04%3A34IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Influence%20of%20N-methyl-D-aspartate%20receptors%20on%20ouabain%20activation%20of%20nuclear%20factor-%CE%BAB%20in%20the%20rat%20hippocampus&rft.jtitle=Journal%20of%20neuroscience%20research&rft.au=Kawamoto,%20E.M.&rft.date=2012-01&rft.volume=90&rft.issue=1&rft.spage=213&rft.epage=228&rft.pages=213-228&rft.issn=0360-4012&rft.eissn=1097-4547&rft_id=info:doi/10.1002/jnr.22745&rft_dat=%3Cproquest_cross%3E905671410%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=905671410&rft_id=info:pmid/22006678&rfr_iscdi=true |